thiazoles has been researched along with Low Bone Density in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buelund, L; Dimopoulou, M; Hansen, MS; Kirpensteijn, J; Nielsen, DH | 1 |
| Baraldi, PG; Bianchini, E; Gambari, R; Lambertini, E; Penolazzi, L; Piva, R; Romagnoli, R | 1 |
| Gowen, M; Nadeau, DP; Nuttall, ME; Olivera, DL; Patton, AJ | 1 |
| Kakimoto, K; Shibata, T; Takeuchi, S; Wakitani, K; Yokota, S; Yonemori, F | 1 |
| Esumi, H; Ito, Y; Kosaka, H; Kurashima, Y; Terada, N; Tsuda, M; Uozumi, M | 1 |
5 other study(ies) available for thiazoles and Low Bone Density
| Article | Year |
|---|---|
Nutritional secondary hyperparathyroidism in two cats: evaluation of bone mineral density with dual-energy X-ray absorptiometry and computed tomography.
Topics: Absorptiometry, Photon; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density; Bone Diseases, Metabolic; Cats; Fatal Outcome; Feeding and Eating Disorders; Female; Hyperparathyroidism; Lameness, Animal; Meloxicam; Thiazines; Thiazoles; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
N-Arylpiperazine modified analogues of the P2X7 receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acid Phosphatase; Apoptosis; Bone and Bones; Bone Diseases, Metabolic; Caspase 3; Caspases; Cell Nucleus; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-6; Isoenzymes; Models, Chemical; NF-kappa B; Osteoblasts; Osteoclasts; Piperazines; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2X7; Tartrate-Resistant Acid Phosphatase; Tetrazolium Salts; Thiazoles; Time Factors | 2005 |
Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders.
Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Alkaline Phosphatase; Animals; Apolipoproteins; Bone Diseases, Metabolic; Calcitriol; Carrier Proteins; Cell Division; Cell Line; Cells, Cultured; Chromans; Cytokines; Dexamethasone; Enzyme Induction; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Glucocorticoids; Humans; Hypoglycemic Agents; Lipoprotein Lipase; Mice; Myelin P2 Protein; Neoplasm Proteins; Nerve Tissue Proteins; Osteoblasts; Osteocalcin; Phosphodiesterase Inhibitors; Thiazoles; Thiazolidinediones; Troglitazone; Tumor Suppressor Proteins | 1998 |
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Cataract; Chromans; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Eating; Hypoglycemic Agents; Isoxazoles; Male; Neural Conduction; Obesity; Pancreas; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone | 2000 |
Marked nitrosation by stimulation with lipopolysaccharide in ascorbic acid-deficient rats.
Topics: Adrenal Glands; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Body Weight; Bone Diseases, Metabolic; Escherichia coli; Female; Kidney; Lipopolysaccharides; Liver; Nitrates; Nitroso Compounds; Rats; Rats, Mutant Strains; Spleen; Thiazoles; Thiazolidines | 1990 |